Growblox Sciences
Las Vegas, US · Nevada corporation
Founders & leadership
CE
Craig EllinsFounder
JP
John PossExecutive
AS
Andrea Small-HowardExecutive
SW
Steven WeldonExecutive
Reported raises · per SEC filings
Form D private placements$24.9M disclosed across 11 rounds · 2014–2023
▶$75KraisedAug 2023 · 2 investors · BiotechnologyRule 506(b)
▶$75KraisedAug 2023 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- John PossExecutive Officer, Director
- Edmond DeFrankDirector
- Andrea Small-HowardExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $75K
- Minimum investment
- $10K
- Sales commissions
- $100K
- Proceeds to insiders
- $60K
- Placement agents
- Network 1 Financial Services, Inc.
- First sale
- Jun 2023
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$25KraisedJun 2022 · 1 investors · BiotechnologyRule 506(b)
▶$25KraisedJun 2022 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Andrea Small-HowardExecutive Officer, Director
- Edmond DeFrankDirector
- Zach SwartsExecutive Officer
- John PossExecutive Officer, Director
- Offering amount
- $565K
- Amount sold
- $25K
- Minimum investment
- $10K
- Sales commissions
- $56.5K
- Proceeds to insiders
- $75K
- Placement agents
- Network 1 Financial Services, Inc.
- First sale
- May 2022
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$240KraisedOct 2019 · 1 investors · BiotechnologyRule 506(b)
▶$240KraisedOct 2019 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- John PossExecutive Officer, Director
- Zach SwartsExecutive Officer
- Andrea Small-HowardExecutive Officer, Director
- Shane TerryDirector
- Leslie BocskorDirector
- Offering amount
- $240K
- Amount sold
- $240K
- Minimum investment
- $240K
- First sale
- Oct 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7.2MraisedOct 2019 · 60 investors · BiotechnologyRule 506(b)
▶$7.2MraisedOct 2019 · 60 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- John PossExecutive Officer, Director
- Zach SwartsExecutive Officer
- Leslie BocskorDirector
- Shane TerryDirector
- Andrea Small-HowardExecutive Officer, Director
- Offering amount
- $7.2M
- Amount sold
- $7.2M
- Minimum investment
- $10K
- Sales commissions
- $720K
- Proceeds to insiders
- $1.1M
- Placement agents
- Network 1 Financial Services. Inc.
- First sale
- Jan 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.9MraisedOct 2019 · 17 investors · BiotechnologyRule 506(b)
▶$2.9MraisedOct 2019 · 17 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- John PossExecutive Officer, Director
- Zach SwartsExecutive Officer
- Leslie BocskorDirector
- Shane TerryDirector
- Andrea Small-HowardExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $2.9M
- Minimum investment
- $10K
- Sales commissions
- $293.2K
- Proceeds to insiders
- $480K
- Placement agents
- Network 1 Financial Services. Inc.
- First sale
- Dec 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2MraisedOct 2019 · 21 investors · BiotechnologyRule 506(b)
▶$2MraisedOct 2019 · 21 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- John PossExecutive Officer, Director
- Andrea Small-HowardExecutive Officer, Director
- Shane TerryDirector
- Leslie BocskorDirector
- Zach SwartsExecutive Officer
- Offering amount
- $2M
- Amount sold
- $2M
- Minimum investment
- $10K
- Sales commissions
- $200K
- Proceeds to insiders
- $320K
- Placement agents
- Network 1 Financial Services. Inc.
- First sale
- Mar 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5MraisedOct 2018 · 28 investors · BiotechnologyRule 506(b)
▶$5MraisedOct 2018 · 28 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Andrea Small-HowardExecutive Officer, Director
- Shane TerryDirector
- John PossExecutive Officer, Director
- Leslie BocskorDirector
- Krin Ellery KuetheExecutive Officer
- Ksenia GriswoldExecutive Officer
- Offering amount
- $5M
- Amount sold
- $5M
- Minimum investment
- $10K
- Sales commissions
- $500K
- Proceeds to insiders
- $800K
- Placement agents
- Network 1 Financial Services, Inc.
- First sale
- Aug 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.9MraisedNov 2017 · 48 investors · BiotechnologyRule 506(b)
▶$3.9MraisedNov 2017 · 48 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Krin Ellery KuetheExecutive Officer
- Shane TerryDirector
- Ksenia GriswoldExecutive Officer
- Andrea Small-HowardExecutive Officer, Director
- John PossExecutive Officer, Director
- Leslie BocskorDirector
- Offering amount
- $6.5M
- Amount sold
- $3.9M
- Minimum investment
- $10K
- Sales commissions
- $506.4K
- Proceeds to insiders
- $800K
- Placement agents
- Network 1 Financial Services, Inc.
- First sale
- Jul 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Growblox Sciences?
- Growblox Sciences was founded by Craig Ellins.
- How much funding has Growblox Sciences raised?
- Growblox Sciences has disclosed $24.9M raised across 11 rounds.
- Where is Growblox Sciences headquartered?
- Growblox Sciences is headquartered in Las Vegas, US.